Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E44.52 EPS (ttm)1.62 Insider Own2.51% Shs Outstand57.86M Perf Week-0.83%
Market Cap4.17B Forward P/E19.79 EPS next Y3.64 Insider Trans-4.63% Shs Float56.48M Perf Month-1.18%
Income94.41M PEG4.11 EPS next Q0.71 Inst Own101.41% Short Float3.51% Perf Quarter-8.82%
Sales1.25B P/S3.33 EPS this Y10.19% Inst Trans1.99% Short Ratio4.59 Perf Half Y9.14%
Book/sh20.77 P/B3.47 EPS next Y9.76% ROA4.73% Short Interest1.98M Perf Year-7.19%
Cash/sh10.17 P/C7.08 EPS next 5Y10.83% ROE8.05% 52W Range62.58 - 85.62 Perf YTD-5.17%
Dividend Est.- P/FCF37.64 EPS past 5Y15.74% ROI4.54% 52W High-15.87% Beta0.92
Dividend TTM- Quick Ratio3.95 Sales past 5Y7.42% Gross Margin41.78% 52W Low15.10% ATR (14)1.65
Dividend Ex-Date- Current Ratio5.45 EPS Y/Y TTM25.11% Oper. Margin9.84% RSI (14)44.70 Volatility2.36% 2.13%
Employees6950 Debt/Eq0.74 Sales Y/Y TTM9.23% Profit Margin7.53% Recom1.60 Target Price93.60
Option/ShortYes / Yes LT Debt/Eq0.73 EPS Q/Q-17.88% Payout0.00% Rel Volume1.24 Prev Close70.99
Sales Surprise1.20% EPS Surprise5.72% Sales Q/Q11.04% EarningsApr 30 AMC Avg Volume432.00K Price72.03
SMA20-1.18% SMA50-4.32% SMA200-1.15% Trades Volume533,932 Change1.46%
Date Action Analyst Rating Change Price Target Change
Apr-11-24Initiated CL King Buy $88
Feb-07-24Initiated BofA Securities Neutral $87
Dec-21-23Upgrade Canaccord Genuity Hold → Buy $100
Dec-20-22Downgrade Canaccord Genuity Buy → Hold $73 → $72
Jan-05-21Upgrade Needham Hold → Buy $65
Sep-28-20Upgrade Wells Fargo Underweight → Equal Weight $42
Feb-25-20Downgrade Barrington Research Outperform → Mkt Perform
Feb-03-20Upgrade Raymond James Mkt Perform → Outperform $43
Dec-12-19Downgrade Wells Fargo Market Perform → Underperform $26
Sep-24-19Initiated Oppenheimer Outperform
Apr-10-24 09:33AM
Mar-29-24 11:30AM
Mar-27-24 09:40AM
Mar-20-24 11:28AM
Mar-19-24 09:25AM
05:19PM Loading…
Mar-18-24 05:19PM
Mar-08-24 05:00PM
Mar-07-24 10:43AM
Mar-05-24 09:25AM
Mar-01-24 04:32AM
Feb-29-24 11:24AM
Feb-28-24 07:00PM
06:15PM Loading…
Feb-23-24 09:15AM
Feb-21-24 10:00AM
Feb-19-24 08:38AM
Feb-15-24 09:25AM
Jan-31-24 12:10PM
Jan-30-24 09:55AM
Jan-24-24 01:01PM
Jan-23-24 07:19AM
Jan-16-24 04:05PM
Jan-08-24 09:00AM
04:05PM Loading…
Jan-03-24 04:05PM
Dec-27-23 05:11AM
Dec-18-23 04:05PM
Dec-15-23 09:50AM
Dec-11-23 10:25AM
Dec-06-23 09:00AM
Dec-04-23 04:05PM
Nov-15-23 07:28AM
Nov-01-23 09:55AM
Oct-31-23 11:40AM
Oct-30-23 01:37AM
Oct-27-23 12:20PM
Oct-26-23 07:30PM
Oct-25-23 10:21AM
Oct-12-23 11:55AM
Oct-10-23 11:40AM
Oct-05-23 11:05AM
Sep-19-23 09:00AM
Sep-07-23 07:22AM
Sep-06-23 09:25AM
Aug-30-23 12:46PM
Aug-15-23 01:20PM
Aug-10-23 07:58AM
Aug-08-23 06:50AM
Aug-03-23 09:25AM
Jul-26-23 12:07PM
Jul-25-23 08:00PM
Jul-21-23 06:51AM
Jul-13-23 11:56AM
Jul-11-23 11:40AM
Jul-07-23 07:20AM
Jul-06-23 01:11PM
Jul-03-23 07:51AM
Jun-26-23 10:50AM
Jun-22-23 11:40AM
Jun-21-23 08:00PM
Jun-19-23 10:24AM
Jun-14-23 11:51AM
Jun-13-23 01:59PM
Jun-09-23 01:39PM
Jun-08-23 04:01PM
Jun-07-23 04:23PM
Jun-06-23 12:37PM
Jun-05-23 02:12PM
Jun-02-23 12:44PM
Jun-01-23 11:28AM
May-31-23 12:07PM
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Parra Raul Jr.CFO AND TREASURERMar 12 '24Sale73.956,480479,18212,007Mar 13 06:36 PM
Wright JosephCHIEF COMMERCIAL OFFICERMar 07 '24Option Exercise28.2025,000705,00067,223Mar 08 03:40 PM
Wright JosephCHIEF COMMERCIAL OFFICERMar 07 '24Sale75.6825,0001,891,92542,223Mar 08 03:40 PM
Peterson NeilCHIEF OPERATING OFFICERMar 06 '24Option Exercise44.807,500336,00014,819Mar 08 10:11 AM
Gunderson Thomas JamesDirectorMar 04 '24Option Exercise34.4025,000860,00037,414Mar 05 12:13 PM
Gunderson Thomas JamesDirectorMar 04 '24Sale76.0318,1571,380,51319,257Mar 05 12:13 PM
Evans Stephen C.DirectorMar 04 '24Sale76.351,00076,3487,226Mar 05 10:13 AM
Millner F. AnnDirectorJan 22 '24Option Exercise34.4020,000688,00049,960Jan 24 10:49 AM
Millner F. AnnDirectorJan 22 '24Sale80.0020,0001,600,00029,960Jan 24 10:49 AM
LAMPROPOULOS FRED PPRESIDENT AND CEOAug 25 '23Option Exercise28.20200,0005,640,0001,167,916Aug 29 06:08 PM
LAMPROPOULOS FRED PPRESIDENT AND CEOAug 25 '23Option Exercise28.206,000169,20012,888Aug 29 06:08 PM
Peterson NeilCHIEF OPERATING OFFICERAug 22 '23Option Exercise28.208,000225,6008,000Aug 23 11:32 AM
Peterson NeilCHIEF OPERATING OFFICERAug 22 '23Sale67.918,000543,2880Aug 23 11:32 AM
ANDERSON A SCOTTDirectorAug 09 '23Option Exercise50.5025,0001,262,50071,397Aug 11 05:30 PM
ANDERSON A SCOTTDirectorAug 09 '23Sale69.4022,1801,539,29249,217Aug 11 05:30 PM